Lundbeck A/S Reports 7% YOY Revenue Increase in Q3 2023 and 9% Growth for the First Three Quarters
Denmark-based biopharmaceutical company H. Lundbeck A/S (CPH: HLUN-A) has announced its financial results for the...
Sandoz Invests in New Biosimilars and Penicillin API Production Sites in Europe
Switzerland-based pharmaceutical company Sandoz (SWX: SDZ) has announced the opening of two new production sites...
Merck Reports Q3 2023 Financial Results with Mixed Performance Across Segments
Germany-based Merck (ETR: MRK) has released its financial results for the third quarter of 2023,...
AimingMed Partners with Becton, Dickinson and Co. to Advance Tumor Precision Medicine
AimingMed, a leading provider of tumor precision medicine solutions based in Hangzhou, has announced a...
China’s NMPA Grants Conditional Approval for Juventas’ CAR-T Therapy Inaticabtagene Autoleucel
The National Medical Products Administration (NMPA) has conditionally approved the marketing of inaticabtagene autoleucel (CNCT...
China’s NMPA Officially Seeks Membership in the Pharmaceutical Inspection Co-operation Scheme (PIC/S)
The Pharmaceutical Inspection Co-operation Scheme (PIC/S) has announced that China’s National Medical Products Administration (NMPA)...
Eli Lilly’s Zepbound Approved by FDA for Chronic Weight Management in Adults
Eli Lilly (NYSE: LLY) has received registration approval from the US Food and Drug Administration...
BeiGene Ltd Reports Q3 2023 Financial Results with 102% YOY Revenue Increase
BeiGene Ltd (NASDAQ: BGNE; HKG: 6160; SHA: 688235) has released its financial results for the...
Danaher Corporation Partners with CHEA to Boost Oncology Centers in Chinese Counties
US-based science and technology services giant Danaher Corporation (NYSE: DHR) has entered into a partnership...
Yantai Dongcheng Pharmaceutical Gets Singapore HSA Nod for Phase I Study of 177Lu-LNC1003
China-based Yantai Dongcheng Pharmaceutical Group Co., Ltd (SHE: 002675) has announced receiving approval from the...
SanegeneBio Partners with Huadong Medicine to Develop RNAi Therapeutics for Metabolic Diseases
Suzhou-based RNA interference (RNAi) therapeutics developer SanegeneBio has entered into a partnership with compatriot firm...
Chongqing Lummy Pharmaceutical’s Generic Ramosetron Passes GQCE in China
China-based Chongqing Lummy Pharmaceutical Co., Ltd (SHE: 300006) has announced that its generic version of...
Shanghai Qingyun Pharmaceutical Teams Up with Organon at CIIE for Remeron Marketing
China’s Shanghai Qingyun Pharmaceutical Technology Co., Ltd has entered into a partnership with US-based Organon...
Sino Medical Sciences Technology Secures EU MDR Approval for HT Supreme Drug-Eluting Stent System
China-based Sino Medical Sciences Technology Inc., (SHA: 688108) has announced that it has received Medical...
Biosmelt Pharma Partners with Shenzhen Eureka Biotechnology for Cell and Gene Therapy Advancements
Shanghai-based cell and gene therapy (CGT) specialist, Biosmelt Pharma, has entered into a partnership with...
Bayer Secures Multiple Procurement Deals at the 6th CIIE
At the 6th China International Import Expo (CIIE) in Shanghai, Germany-headquartered Bayer (ETR: BAYN) announced...
ayer Partners with Changzhou Qianhong Bio-pharma to Advance Digestive Health Solutions
Germany-headquartered Bayer (ETR: BAYN) has entered into a partnership with China-based Changzhou Qianhong Bio-pharma Co.,...
Sirius Therapeutics Pursues First-in-Human Trial for SRSD107 in Australia
Sino-US biotech Sirius Therapeutics has announced its pursuit of Investigational New Drug (IND) approval in...
ImmVira’s MVR-T3011 IV Achieves Positive Outcomes in US Phase I Clinical Study
Shenzhen-based biotechnology company ImmVira has announced the successful completion of Phase I clinical studies in...
Establishment Labs Receives NMPA Approval for Motiva Silicone Gel-Filled Breast Implants
US-based medical technology company Establishment Labs Holdings Inc., (NASDAQ: ESTA) has announced that it has...